Anti-HIV-1 and cytotoxicity studies of piperidyl-thienyl chalcones and their 2-pyrazoline derivatives
Tóm tắt
Từ khóa
Tài liệu tham khảo
Azarifar D, Shaebanzadeh M (2002) Synthesis and characterization of new 3,5-dinaphthyl substituted 2-pyrazolines and study of their antimicrobial activity. Molecules 7:885–895
Ballesteros JF, Sanz MJ, Ubeda A, Miranda MA, Iborra S, Paya M, Alcaraz M (1995) Synthesis and pharmacological evaluation of 2′-hydroxychalcones and flavones as inhibitors of inflammatory mediators generation. J Med Chem 38:2794–2797
Barsoum FF, Hosni HM, Girgis AS (2006) Novel bis(1-acyl-2-pyrazolines) of potential anti-inflammatory and molluscicidal properties. Bioorg Med Chem 14:3929–3937
Belen’kii MS, Schinazi RF (1994) Multiple drug effect analysis with confidence interval. Antiviral Res 25:1–11
Bilgin AA, Palaska E, Sunal R (1993) Studies on the synthesis and antidepressant activity of some 1-thiocarbamoyl-3,5-diphenyl-2-pyrazolines. Arzneimforsch Drug Res 43:1041–1044
Boeck P, Falcão CAB, Leal PC, Yunes RA, Filho VC, Santos ECT, Bergmann BR (2006) Synthesis of chalcone analogues with increased antileishmanial activity. Bioorg Med Chem 14:1538–1545
Budakoti A, Abid M, Azam A (2006) Synthesis and antiamoebic activity of New 1-N-substituted thiocarbamoyl-3,5-diphenyl-pyrazoline derivatives and their Pd(ll) complexes. Eur J Med Chem 41:63–70
Lévai A (2005) Synthesis of chlorinated 3,5-diaryl-2-pyrazolines by the reaction of chlorochalcones with hydrazines. ARKIVOC 9:344–352
Lévai A, Silva AMS, Pinto DCGA, Cavaleiro JAS, Alkorta I, Elguero J, Jekő J (2004) Synthesis of pyrazolyl-2-pyrazolines by treatment of 3-(3-aryl-3-oxopropenyl)-chromen-4-ones with hydrazine and their oxidation to bis(pyrazoles). Eur J Org Chem 2004:4672–4679
Mukherjee S, Kumar V, Prasad AK, Raj HG, Brakhe ME, Olsen CE, Jain SC, Parmar VP (2001) Synthetic and biological activity evaluation studies on novel 1,3-diarylpropenones. Bioorg Med Chem 9:337–339
Nauduri D, Reddy GB (1998) Antibacterial and antimycotics Part 1: synthesis and activity of 2-pyrazoline derivatives. Chem Pharm Bull Tokyo 46:1254–1260
Nowakowska Z (2007) A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 42:125–137
Ozdemir Z, Kandilici HB, Gumusel B, Calis U, Bilgin AA (2007) Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives. Eur J Med Chem 42:373–379
Ramalingham K, Thyvekikakath GX, Berlin KD, Chesnut RW, Brown RA, Durham NN, Ealick SE, Van der Helm D (1977) Synthesis and biological activity of some derivatives of thiochroman-4-one and tetrahydrothiapyran-4-one. J Med Chem 20:847–850
Schinazi RF, Sommadossi PJ, Cannon DL, Xie MY, Hart GC, Smith JA, Hahan EF (1990) Activities of 3′-azido-3′-deoxythymidine nucleotide dimers in primary lymphocytes infected with human Immunodeficiency virus type 1. Antimicrobial Agents Chemother 34:1061–1067
Sivakumar PM, Geetha Babu SK, Mukesh D (2007) QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using genetic function approximation (GFA) method. Chem Pharm Bull 55:44–49
Stuyver LJ, Lostia S, Adams M, Mathew SJ, Pai SB, Grier J, Tharnish MP, Choi Y, Chong Y, Choo H, Chu KC, Otto JM, Schinazi FR (2002) Antiviral activities and cellular toxicities of modified 2′,3′-dideoxy-2′,3′-didehydrocytidine analogues. Antimicrob Agents Chemother 46:3854–3860
Taylor EC, Patel HH (1992) Synthesis of pyrazolo[3,4,-d]pyrimidine analogues of the potent antitumor agent N-{4-[2-(2-amino-4(3H)-oxo-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-l-glutamic acid (LY231514). Tetrahedron 48:8089–8100
Tiwari N, Dwivedi B, Nizamuddin (1989) Synthesis of some pyrazoline and isooxazolin derivatives as possible fungicides. Boll Chim Farm 128:332–335
Trivedi JC, Bariwal JB, Upadhyay KD, Naliapara YT, Joshi SK, Pannecouque CC, Clercq ED, Shah AK (2007) Improved and rapid synthesis of new coumarinyl chalcone derivatives and their antiviral activity. Tetrahedron Lett 48:8472–8474
Viana GS, Bandeira MA, Matos F (2003) Analgesic and antiinflamatory effects of chalcones isolated from Myracrodrum Urundeiva. J Phytomedicine 10:189–195
Wattenberg LW, Coccia JB, Galbraith AR (1994) Inhibition of carcinogen-induced pulmonary and mammarycarcinogenesis by chalcone administered subsequent to carcinogen exposure. Cancer Lett 83:165–169
Wu X, Wilairat P, Go M (2002) Antimalarial activity of ferrocenyl chalcones. Bioorg Med Chem Lett 12:2299–2302